Chang H C, Bao Z, Yao Y, Tse A G, Goyarts E C, Madsen M, Kawasaki E, Brauer P P, Sacchettini J C, Nathenson S G
Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA.
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11408-12. doi: 10.1073/pnas.91.24.11408.
Generation of soluble T-cell receptor (TCR) molecules by a variety of genetic engineering methods has been hampered by inefficient pairing of alpha and beta subunits in the absence of their respective transmembrane regions and associated CD3 components. To overcome this obstacle, we have added 30-amino acid-long segments to the carboxyl termini of alpha and beta extracellular domains via a cleavable flexible linker. These peptide segments (BASE-p1 for alpha and ACID-p1 for beta) have been previously shown to selectively associate to form a stable heterodimeric coiled coil termed a leucine zipper. Homodimeric structures are not permitted due to electrostatic repulsion among amino acid side chains. Expression of a representative TCR-leucine zipper fusion protein in a baculovirus expression system results in production of alpha beta TCR heterodimer at 0.6-1.4 mg/liter. This yield is 5- to 10-fold greater than that of the TCR expressed in the absence of the synthetic leucine zipper sequence. The structure of the TCR component of the fusion heterodimer was judged to be native when probed with a panel of 17 mAbs specific for alpha and beta constant and variable domains. A mAb specific for the isolated BASE-p1/ACID-p1 coiled coil was also generated and shown to react with the TCR fusion protein. The above technology should be broadly useful in the efficient production and purification of TCRs as well as other heterodimeric proteins.
通过多种基因工程方法生成可溶性T细胞受体(TCR)分子,一直受到α和β亚基在缺乏各自跨膜区域及相关CD3组件时配对效率低下的阻碍。为克服这一障碍,我们通过可裂解的柔性接头在α和β细胞外结构域的羧基末端添加了30个氨基酸长的片段。这些肽段(α的为BASE-p1,β的为ACID-p1)先前已被证明能选择性缔合形成一种稳定的异源二聚体卷曲螺旋,称为亮氨酸拉链。由于氨基酸侧链之间的静电排斥,不允许形成同二聚体结构。在杆状病毒表达系统中表达一种代表性的TCR-亮氨酸拉链融合蛋白,可产生浓度为0.6 - 1.4毫克/升的αβ TCR异二聚体。该产量比在没有合成亮氨酸拉链序列时表达的TCR产量高5至10倍。当用一组针对α和β恒定区及可变区的17种单克隆抗体进行检测时,融合异二聚体的TCR组件结构被判定为天然结构。还制备了一种针对分离的BASE-p1/ACID-p1卷曲螺旋的单克隆抗体,并证明其能与TCR融合蛋白发生反应。上述技术在TCR以及其他异二聚体蛋白的高效生产和纯化方面应具有广泛的用途。